In another study, the frequency of the CD44+/CD24- population—marking breast cancer stem cells (CSCs)—was diminished, and the expression and activation of the pro-inflammatory IL-6/STAT3 pathway reduced after Sdc-1 siRNA knockdown [16]. Here, CD44 is linked to breast carcinoma.